XW013T6
Introduction of COVID-19 Vaccine Dose 2 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6
| Pos | Category | Selected Element & Definition |
|---|---|---|
| X | Section |
New Technology
|
| W | Body System |
Anatomical Regions
|
| 0 | Operation |
Introduction
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
|
| 1 | Body System / Region |
Subcutaneous Tissue
|
| 3 | Approach |
Percutaneous
|
| T | Device / Substance / Technology |
Rozanolixizumab-noli Monoclonal Antibody
|
| 6 | Qualifier |
New Technology Group 6
|